Baxter Infuses Pump Franchise With Sigma Technology
This article was originally published in The Gray Sheet
Executive Summary
Baxter is augmenting its troubled infusion pump franchise with Sigma's Spectrum smart pump technology under a $100 million licensing agreement announced April 15
You may also be interested in...
News In Brief
Orthofix unloads sports medicine unit. Baxter completes Sigma purchase. Edwards Lifesciences’ Sapien update. More news briefs.
Mandatory Baxter Infusion Pump Recall Will Cost Up To $600 Million
Baxter will recall all of its Colleague infusion pumps on the U.S. market at an initial cost of up to $600 million, the firm disclosed May 3
Mandatory Baxter Infusion Pump Recall Will Cost Up To $600 Million
Baxter will recall all of its Colleague infusion pumps on the U.S. market at an initial cost of up to $600 million, the firm disclosed May 3